
Ark Therapeutics has announced that Kassim Kolia has been appointed as head of business development. In this role, Kolia will …
How long has your company been operating? Eden Biodesign is enjoying its tenth anniversary this year. How is your field …
UK biologics manufacturing specialist Eden Biodesign has been bought by US drugmaker Watson Pharmaceuticals in a $15 million deal. The …
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer

